
Open Innovation a Must in New Drug Development
The Korea Biomedical Review reported that the Korea Pharmaceutical and Bio-Pharma Manufacturers Association and the Korea Research-based Pharma Industry Association recently held a meeting of the government, pharmaceutical representatives, and experts. “As research and development activities for new drugs are becoming open innovation-based ones,
Comments Off on Open Innovation a Must in New Drug Development • Read this story »